Agile Therapeutics (AGRX)
(Delayed Data from OTC)
$1.43 USD
0.00 (0.00%)
Updated Jul 10, 2024 11:58 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Agile Therapeutics, Inc. [AGRX]
Reports for Purchase
Showing records 41 - 51 ( 51 total )
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Twirla Sticky Situation; CRL a Big Letdown, But We See it as Just Another Delay; Reiterate Buy but Lower to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Analyst Day Signals Twirla Approval Confidence and Physician Interest; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Transferring Coverage; Analyst Day to Stoke Confidence Ahead of Twirla PDUFA; Assuming With a Buy and $10 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Twirla Taxiing to Runway as NDA Re-submission Accepted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Approvable Twirla Patch and Valuation Mismatch; Initiate with Buy and $10 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C